Cargando…

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study

AIM: To evaluate the safety of efpeglenatide, a long‐acting glucagon‐like peptide‐1 receptor agonist (GLP‐1RA), and its effects on body weight management in adults without diabetes. MATERIALS AND METHODS: In this phase II, randomized, placebo‐controlled, double‐blind trial, participants with a body...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pratley, Richard E., Kang, Jahoon, Trautmann, Michael E., Hompesch, Marcus, Han, OakPil, Stewart, John, Sorli, Christopher H., Jacob, Stephan, Yoon, Kun‐Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851541/ https://www.ncbi.nlm.nih.gov/pubmed/31264757 http://dx.doi.org/10.1111/dom.13824

Ejemplares similares

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study
por: Hompesch, Marcus, et al.
Publicado: (2021)

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
por: Pratley, Richard E, et al.
Publicado: (2022)

Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes
por: Yoon, Kun‐Ho, et al.
Publicado: (2020)

Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study
por: Del Prato, Stefano, et al.
Publicado: (2020)

PSUN305 A Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Obese or Overweight Subjects with Co-morbidities
por: Shin, Wonjung, et al.
Publicado: (2022)

Safety and Efficacy of Efpeglenatide in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Escobar, Johao, et al.
Publicado: (2023)

Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial
por: Frias, Juan Pablo, et al.
Publicado: (2022)

Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2010)

Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase
por: Morrow, Linda, et al.
Publicado: (2013)

Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase
por: Hompesch, Marcus, et al.
Publicado: (2011)

Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits
por: Ok, Duck-Pil, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
por: Luque, Sonia, et al.
Publicado: (2021)

Device Identification Interoperability in Heterogeneous IoT Platforms †
por: Koo, Jahoon, et al.
Publicado: (2019)

Oral Semaglutide Reduces HbA(1c) and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses
por: Pratley, Richard E., et al.
Publicado: (2021)

Feeding Period Restriction Alters the Expression of Peripheral Circadian Rhythm Genes without Changing Body Weight in Mice
por: Jang, Hagoon, et al.
Publicado: (2012)

Association between the APOA2 promoter polymorphism and body-weight in Mediterranean and Asian populations. Replication of a gene-saturated fat interaction
por: Corella, Dolores, et al.
Publicado: (2010)

Regulation of Cdc42 for polarized growth in budding yeast
por: Miller, Kristi E., et al.
Publicado: (2020)

Prepregnancy Maternal Weight and Body Mass Index of Children with and without Congenital Heart Disease
por: Ghaderian, Mehdi, et al.
Publicado: (2014)

Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients
por: Baker, Brian, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males
por: Hompesch, Marcus, et al.
Publicado: (2021)

Body Weight and Body Image
por: Olmsted, Marion P, et al.
Publicado: (2004)

A Case of Endobronchial Aspergilloma Associated with Foreign Body in Immunocompetent Patient without Underlying Lung Disease
por: Jung, Seung Won, et al.
Publicado: (2013)

GIP: An Inconsequential Incretin or Not?
por: Pratley, Richard E.
Publicado: (2010)

Linagliptin use in older individuals with type 2 diabetes
por: Pratley, Richard E
Publicado: (2014)

Daptomycin dosing in obese patients: analysis of the use of adjusted body weight versus actual body weight
por: Fox, Ashley N., et al.
Publicado: (2019)

Comparison of the condyle-fossa relationship between skeletal class III malocclusion patients with and without asymmetry: a retrospective three-dimensional cone-beam computed tomograpy study
por: Kim, Hyoun Oak, et al.
Publicado: (2013)

Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice
por: Asagami, Tomoko, et al.
Publicado: (2011)

Genetic association of swine leukocyte antigen class II haplotypes and body weight in Microminipigs
por: Matsubara, Tatsuya, et al.
Publicado: (2018)

Body weight gain rather than body weight variability is associated with increased risk of nonalcoholic fatty liver disease
por: Cho, Eun Ju, et al.
Publicado: (2021)

Increased weight loading reduces body weight and body fat in obese subjects – A proof of concept randomized clinical trial
por: Ohlsson, Claes, et al.
Publicado: (2020)

Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH
por: Vilalta, Adrian, et al.
Publicado: (2022)

Evaluation of Body Weight, Body Condition, and Muscle Condition in Cats with Hyperthyroidism
por: Peterson, M.E., et al.
Publicado: (2016)

Polymorphism of the FTO Gene Influences Body Weight in Children with Type 1 Diabetes without Severe Obesity
por: Łuczyński, Włodzimierz, et al.
Publicado: (2014)

Effect of Body Weight on Echocardiographic Measurements in 19,866 Pure‐Bred Cats with or without Heart Disease
por: Häggström, J., et al.
Publicado: (2016)

Longitudinal changes in desired body weight compared to changes in body weight: evidence of adaptation to weight gain?
por: Aars, Nils Abel, et al.
Publicado: (2016)

Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors
por: Dittus, Kim L., et al.
Publicado: (2018)

Body Image and Body Avoidance Nine Years After Bariatric Surgery and Conventional Weight Loss Treatment
por: Legenbauer, Tanja, et al.
Publicado: (2020)

The Relationship of the Body-Weight to the Weights of the Organs. The Brain
por: Gharpure, P. V., et al.
Publicado: (1950)

The Relationship of the Body-Weight to the Weights of the Organs. The Heart
por: Gharpure, P. V., et al.
Publicado: (1949)

The impact of excess body weight at the hospital frontline
por: Renehan, Andrew G, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jgrhotkrn3fh535dq2ar2jbi12